| 发明名称 |
Liquid preparation comprising pimobendan |
| 摘要 |
A liquid preparation includes an etherified cyclodextrin derivative and a substituted benzimidazol, where the etherified cyclodextrin derivative is one of alpha-, beta, and gamma-cyclodextrin ether. |
| 申请公布号 |
US9616134(B2) |
申请公布日期 |
2017.04.11 |
| 申请号 |
US201414261838 |
申请日期 |
2014.04.25 |
| 申请人 |
Boehringer Ingelheim Vetmedica GmbH |
发明人 |
Folger Martin;Lehner Stefan |
| 分类号 |
A61K31/33;A61K47/40;A61K9/00;A61K9/08;A61K31/501;A61K47/48;B82Y5/00 |
主分类号 |
A61K31/33 |
| 代理机构 |
|
代理人 |
Morris Michael P.;Gombert Wendy M. |
| 主权项 |
1. A liquid preparation comprising an etherified cyclodextrin derivative and pimobendan or a pharmaceutically acceptable salt thereof, wherein the etherified cyclodextrin derivative is selected from the group consisting of alpha-, beta, and gamma-cyclodextrin ether, and wherein the liquid preparation has a pH of 5.5 to 8.5. |
| 地址 |
Ingelheim am Rhein DE |
